Shopping Cart

0

Your shopping bag is empty

Go to the shop

Omega-3 fatty acids that are harvested through sustainable fishing practices, short lived small fish low on the food chain that are less likely to be exposed to toxins and wild sourced (less saturated fat, and no antibiotic or hormone residues). Optimal 2:1 ratio of EPA to DHA in a lemon flavoured liquid. Clinical dosing of 1500 mg EPA and 750 mg DHA in triglyceride form, and 1000 IU Vitamin D3 per teaspoon.

Supports

  • Cardiovascular Health -atherosclerotic burden, reducing triglyceride levels and blood pressure, and improving platelet and vascular function
  • Brain Health
  • Anti-Inflammatory - Autoimmune

    Feature Ingredients

    • The pharmaceutical grade omega-3 blend, USP verified for quality and consistency of the fish oil
    • Free from lipid peroxides and environmental pollutants including heavy metals, pesticides, dioxins, PCBs and other harmful compounds
    • Sourced from wild anchovies, sardines, and/or mackerel, some of the best natural sources of EPA and DHA

                    Vitamin D and omega-3 fatty acids from fish oil are among the most powerful nutrients for improving overall health, and they are also among the most commonly deficient.
                    • EPA and DHA improve a number of cardiovascular risk factors including lowering of atherosclerotic burden, reducing triglyceride levels and blood pressure, and improving platelet and vascular function.1,2,3,4
                    • Vitamin D has also been shown to modify cardiovascular risk and reduce the risk of several cancers, autoimmune disease, osteoporotic fractures, and overall mortality.5,6,7,8,9
                    • EPA and DHA are essential to the resolution of inflammatory processes, as well as tissue repair, by providing the substrates for anti-inflammatory prostaglandins, resolvins and protectins, and vitamin D has recently been shown to have anti-inflammatory effects as well.10,11,12
                    • Omega-3 fatty acids are incorporated into membrane phospholipids, affecting cellular membrane organization, ion permeability, intracellular signalling, gene expression and the activity of membrane-associated proteins.13
                    • EPA and DHA combined with vitamin D are likely to have synergistic benefits for improving overall wellness, as well as for preventing and treating a wide variety of cardiovascular, inflammatory and autoimmune conditions.14

                          Service Size: 1 teaspoon (5 mL)

                          Servings per Container:  40

                          Medicinal Ingredients

                          Each Teaspoon (5 ml) Contains:  
                          Fish Oil (Anchovy, Sardine and/or Mackerel) 4500 mg
                          Omega-3 Fatty Acids 2630 mg
                          Eicosapentaenoic Acid (EPA)  1500 mg
                          Docosahexaenoic Acid (DHA) 750 mg
                          Vitamin D3 (Cholecalciferol)  1000 IU (25 mcg)

                          Non-Medicinal Ingredients

                          Lemon flavour, lemon peel essential oil, tocopherols, monk fruit extract.

                          Allergens

                          Contains No Added: artificial colours, preservatives, or sweeteners; dairy, sugar, wheat, gluten, yeast, soy, corn, egg, shellfish, salt, tree nuts, or GMOs.  Sealed for your protection. Do not use if seal is broken. Refrigerate after opening. Store in airtight container, protected from light.

                          Recommended Use

                          Adults 19+: 1 teaspoon (5 ml) per day or as directed by a health care practitioner. 

                          Bioclinic Naturals Advantage

                          Highly bioavailable ingredients for optimal absorption.

                          Contraindications

                          Do not use if you are hypersensitive or allergic to any of the ingredients. 

                          Caution

                          Consult a health care practitioner prior to use if you are taking any medications (especially blood thinners or blood pressure medication) or if you have any pre-existing condition.  Discontinue this product 2 weeks prior to surgery.

                          Individuals with an allergy to fish or seafood should use caution, though fish oil is rarely allergenic. Both benefit and risk has been documented for those at risk of or being treated for cardiac arrhythmias, with close supervision indicated.15 Pregnant and nursing women are often advised to consume a minimum of 300 mg DHA per day, and although DHA is recognized as essential to neurological development, no dosage recommendations have been made for children or infants. Supplemental vitamin D should be used with caution in those with sarcoidosis, lymphoma, tuberculosis, hypercalcemia or renal impairment.16

                          The antihypertensive effect of fish oil and/or vitamin D may potentially reduce the need or dosage for blood pressure medications, and patients should be closely monitored. Because fish oil has an antithrombotic effect, caution is advised for those on anticlotting, antiplatelet or anticoagulant medications, or those at high risk of bleeding.17 At doses greater than 3 g per day, hyperglycemia has been observed in diabetics and those with hypertriglyceridemia and close monitoring of patients on antidiabetic medication is recommended. Vitamin D may increase the risk for hypercalcemia when taken with a thiazide medication (diuretic).18 Benefit has been shown when fish oil is taken with statins, SSRIs, anticonvulsant and cytotoxic medications.19,20

                          Side Effect Risks

                          Discontinue use and consult a healthcare practitioner if symptoms persist, worsen or you develop any reactions which may include: allergy or intolerance. Keep out of reach of children. Sealed for your protection. Do not use if seal is broken. For freshness, store in a cool, dry place.

                          Disclaimer

                          The information and product descriptions that appear on this website are for information and educational purposes only and are not intended to provide or replace medical advice to individuals from qualified health care professionals. Consult your physician if you have any health concerns, and before initiating any new dietary, exercise, supplements or other lifestyle changes.

                          References

                          1. Pischon T, Hankinson SE, Hotamisligil GS, et al. Habitual dietary intake of omega-3 and omega-6 fatty acids in relation to inflammatory markers among US men and women. Circulation. 2003 Jul 15;108(2):155-60.
                          2. Swanson D, Block R, Mousa SA. Omega-3 fatty acids EPA and DHA: health benefits throughout life. Adv Nutr. 2012;3:1-7.
                          3. Wang C, Harris WS, Chung M, et al. n-3 Fatty acids from fish or fish-oil supplements, but not alpha-linolenic acid, benefit cardiovascular disease outcomes in primary- and secondaryprevention studies: a systematic review. Am J Clin Nutr. 2006 Jul;84(1):5-17.
                          4. Saito Y, Yokoyama M, Origasa H, et al. Effects of EPA on coronary artery disease in hypercholesterolemic patients with multiple risk factors: sub-analysis of primary prevention cases from the Japan EPA Lipid Intervention Study (JELIS). Atherosclerosis. 2008 Sep;200(1):135-40.
                          5. Muscogiuri G, Sorice GP, Ajjan R, Mezza T, Pilz S, Prioletta A, Scragg R, Volpe SL, Witham MD, Giaccari A. Can vitamin D deficiency cause diabetes and cardiovascular diseases? Present evidence and future perspectives. Nutr Metab Cardiovasc Dis. 2012 Feb;22(2):81-7.
                          6. Fletcher JM, Basdeo SA, Allen AC, Dunne PJ. Therapeutic use of vitamin D and its analogues in autoimmunity. Recent Pat Inflamm Allergy Drug Discov. 2012 Jan;6(1):22-34.
                          7. Baz-Hecht M, Goldfine AB. The impact of vitamin D deficiency on diabetes and cardiovascular risk. Curr Opin Endocrinol Diabetes Obes. 2010 Apr;17(2):113-9.
                          8. Zittermann A, Prokop S. The role of vitamin D for cardiovascular disease and overall mortality. Adv Exp Med Biol. 2014;810:106-19.
                          9. Chowdhury R, Kunutsor S, Vitezova A, et al. Vitamin D and risk of cause specific death: systematic review and meta-analysis of observational cohort and randomised intervention studies. BMJ. 2014 Apr 1;348:g1903. doi: 10.1136/bmj.g1903.
                          10. Yedgar S, Krimsky M, Cohen Y, et al. Treatment of inflammatory diseases by selective eicosanoid inhibition: a double-edged sword? Trends Pharmacol Sci. 2007 Sep;28(9):459-64.
                          11. Schmitz G, Ecker J. The opposing effects of omega-3 and omega-6 fatty acids. Prog Lipid Res. 2008 Mar;47(2):147-55.
                          12. Zanetti M, Harris SS, Dawson-Hughes B. Ability of vitamin D to reduce inflammation in adults without acute illness. Nutr Rev. 2014 Feb;72(2):95-8. doi: 10.1111/nure.12095.
                          13. Jung UJ, Torrejon C, Tighe AP, et al. n-3 Fatty acids and cardiovascular disease: mechanisms underlying beneficial effects. Am J Clin Nutr. 2008 Jun;87(6):2003S-9S.
                          14. Manson JE, Bassuk SS, et al. The Vitamin D and OmegA-3 TriaL (VITAL): rationale and design of a large randomized controlled trial of vitamin D and marine omega-3 fatty acid supplements for the primary prevention of cancer and cardiovascular disease. Contemp Clin Trials. 2012 Jan;33(1):159-71.
                          15. Kromhout D, de Goede J. Update on cardiometabolic health effects of -3 fatty acids. Curr Opin Lipidol. 2014 Feb;25(1):85-90.
                          16. Sage RJ, Rao DS, Burke RR, Lim HW. Preventing vitamin D toxicity in patients with sarcoidosis. J Am Acad Dermatol. 2011 Apr;64(4):795-6.
                          17. Harris WS. Expert opinion: omega-3 fatty acids and bleeding-cause for concern? Am J Cardiol. 2007 Mar 19;99(6A):44C-46C.
                          18. Boulard JC, Hanslik T, Alterescu R, Baglin A. [Symptomatic hypercalcemia after vitamin D-thiazide diuretics combination. Two cases in elderly women]. Presse Med. 1994 Jan 22;23(2):96.
                          19. Toyama K, Nishioka T, Isshiki A, et al. Eicosapentaenoic Acid combined with optimal statin therapy improves endothelial dysfunction in patients with coronary artery disease. Cardiovasc Drugs Ther. 2014 Feb;28(1):53-9.
                          20. Mischoulon D, Freeman MP. Omega-3 fatty acids in psychiatry. Psychiatr Clin North Am. 2013 Mar;36(1):15-23.